Westfield Capital Management CO LP Revolution Medicines, Inc. Transaction History
Westfield Capital Management CO LP
- $21.6 Billion
- Q4 2024
A detailed history of Westfield Capital Management CO LP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Westfield Capital Management CO LP holds 5,799 shares of RVMD stock, worth $216,592. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,799Holding current value
$216,592% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RVMD
# of Institutions
297Shares Held
168MCall Options Held
920KPut Options Held
1.06M-
Vanguard Group Inc Valley Forge, PA17.1MShares$639 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$501 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.2MShares$495 Million3.09% of portfolio
-
Janus Henderson Group PLC London, X09.48MShares$354 Million0.22% of portfolio
-
Baker Bros. Advisors LP New York, NY7.94MShares$296 Million3.85% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.28B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...